XOMA
XOMA
NASDAQ · Biotechnology

Xoma Royalty Corporation

Small-Cap Stocks Biotech Stocks Healthcare Stocks
$41.62
+0.33 (+0.80%)
As of May 9, 1:53 AM ET ·
Analyst Consensus
Buy
10
Analysts
Moderate
Coverage
Buy 6 60%
Hold 4 40%
Sell 0 0%
Price Target
Analyst Price Target -3.8% upside
Low Target $30.13
Average Target $40.02
High Target $66.99
Current Price $41.62
Current
$41.62
Target
$40.02
$30.13 $40.02 avg $66.99
Scenario Analysis
Bear Case
$30.13
-27.6%
Low target
Base Case
$40.02
-3.8%
Avg target
Bull Case
$66.99
+61.0%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$42.81
-2.8% from high
52-Week Low
$22.29
+86.7% from low
Target vs 52W High
$40.02
-6.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 28 96% $143.40 +41.5%